Journals / Turkish journal of nephrology (Online) / 2020 / Cilt: 29 - Sayı: 4

Clinical Features and Outcomes of Patients with Granulomatosis with Polyangiitis and Review of Literature

Pages
279–288
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The delay in diagnosis could have influenced the development of irreversible kidney damage, one of the significant determinants of mortality.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Granulomatosis with polyangiitis (GPA) is a type of antineutrophil cytoplasm antibody-associated vasculitis.
📊
Key Findings & Data:This study aimed to investigate the clinical and laboratory findings of patients with GPA and to determine which factors were associated with poor prognosis and renal outcome.Materials and Methods: Medical records of patients diagnosed with GPA between 2000 and 2014 were retrospectively analyzed.Results: A total of 53 patients (60.4% men) with a mean age at diagnosis of 47.1±16.3 years were included in this study.
💡
Conclusion & Impact:The delay in diagnosis could have influenced the development of irreversible kidney damage, one of the significant determinants of mortality.
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: Granulomatosis with polyangiitis (GPA) is a type of antineutrophil cytoplasm antibody-associated vasculitis. This study aimed to investigate the clinical and laboratory findings of patients with GPA and to determine which factors were associated with poor prognosis and renal outcome.Materials and Methods: Medical records of patients diagnosed with GPA between 2000 and 2014 were retrospectively analyzed.Results: A total of 53 patients (60.4% men) with a mean age at diagnosis of 47.1±16.3 years were included in this study. The median baseline serum creatinine (SCr) level was 1 (interquartile range [IQR], 0.76-2.95) mg/dL. Renal involvement was detected in 63.5% of the patients. Patients with renal involvement had less ear-nose-throat involvement (p=0.002) and lower hematocrit levels (p=0.001). The 1-year, 5-year, and 10-year death-censored renal survival rates were 93.3%, 81.4%, and 63.4%, respectively. There were 15 deaths (28.3%) in this series, and the median patient survival after diagnosis was 51 (IQR, 20-109.5) months. Age ≥65 years and SCr level ≥1.4 mg/dL at diagnosis were retained as the independent predictors of mortality.Conclusion: Survival of patients with GPA is closely associated with age and renal function at admission. The delay in diagnosis could have influenced the development of irreversible kidney damage, one of the significant determinants of mortality.

🔖

Cite This Article

DAVULCU, E. A., ORUÇ, M., YALIN, S. F., ALAGÖZ, S., DEMİR, H., HATEMİ, G., TRABULUS, S., ALTIPARMAK, M. R. (2020). Clinical Features and Outcomes of Patients with Granulomatosis with Polyangiitis and Review of Literature. Turkish journal of nephrology (Online), Cilt: 29 - Sayı: 4, 279–288. https://ajindex.com/articles/374830

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Falk RJ, Gross WL, Guillevin L, Hoffman GS, Jayne DRW, Jennette JC, et al. Granulomatosis with polyangiitis (Wegener's): An alternative name for Wegener's granulomatosis. Arthritis Rheum 2011
  2. [Crossref] 2. Wallace ZS, Lu N, Unizony S, Stone JH, Choi HK. Improved survival in granulomatosis with polyangiitis: A general population-based study. Semin Arthritis Rheum 2016
  3. [Crossref] 3. Holle JU, Laudien M, Gross WL. Clinical manifestations and treatment of Wegener's granulomatosis. Rheum Dis Clin North Am 2010
  4. [Crossref] 4. Binda V, Moroni G, Messa P. ANCA-associated vasculitis with renal involvement. J Nephrol 2018
  5. [Crossref] 5. Rathi M, Pinto B, Dhooria A, Sagar V, Mittal T, Rajan R, et al. Impact of renal involvement on survival in ANCA-associated vasculitis. Int Urol Nephrol 2016
  6. [Crossref] 6. Luqmani RA, Bacon PA, Beaman M, Scott DG, Emery P, Lee SJ, et al. Classical versus non-renal Wegener's granulomatosis. Q J Med 1994
  7. Reinhold-Keller E, Beuge N, Latza U, de Groot K, Rudert H, Nölle B, et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long-term outcome in 155 patients. Arthritis Rheum 2000
  8. [Crossref] 8. Mahr A, Girard T, Agher R, Guillevin L. Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up. Rheumatology (Oxford) 2001
  9. [Crossref] 9. Koldingsnes W, Nossent H. Predictors of survival and organ damage in Wegener's granulomatosis. Rheumatology (Oxford) 2002
  10. [Crossref] 10. Bligny D, Mahr A, Toumelin PL, Mouthon L, Guillevin L. Predicting mortality in systemic Wegener's granulomatosis: A survival analysis based on 93 patients. Arthritis Rheum 2004
  11. [Crossref] 11. Pamuk ÖN, Dönmez S, Calayır GB, Pamuk GE. The epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in northwestern Turkey. Clin Rheumatol 2016
  12. [Crossref] 12. Şen N, Aydın Tufan M, Yıldız R, Ersözlü Bozkırlı ED, Yücel E. Granulomatous polyangitis (Wegener granulomatosis): Clinical findings and results of long-term follow-up. Tuberk Toraks 2016
  13. [Crossref] 13. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990
  14. [Crossref] 14. Mukhtyar C, Lee R, Brown D, Ca